INVESTIGADORES
PALMA Santiago Daniel
artículos
Título:
Transdermal Delivery of Probenecid: the Effects of Vehicles
Autor/es:
LUCÍA LHEZ; DANIEL A. ALLEMANDI; SANTIAGO D. PALMA; NORA B. PAPPANO; NORA B.DEBATTISTA
Revista:
ACTA FARM. BONAERENSE
Editorial:
COLEGIO FARMACEUTICOS PROVINCIA DE BUENOS AIRES
Referencias:
Año: 2010 vol. 29 p. 602 - 606
ISSN:
0326-2383
Resumen:
Vehicles and enhancers effect on in vitro probenecid permeation through dermatomed abdominal pig skin was investigated. The permeability of different probenecid percentages dispersed in vehicles as vaseline, carbopol/ethanol/water and carbopol/propylene glycol was tested. The 1.3% L-menthol addition, as permeation enhancer, over probenecid/vaseline formulations showed the highest values for both, flux and permeation coefficient. Permeation experiments of the probenecid formulations in carbopol/ propylene glycol showed that the carbopol/probenecid concentration relation is the most important issue to be considered. Comparatively to lipophilic vehicle (vaseline), carbopol dispersions seen to be more convenient as vehicle for topical administration of probenecid. The results obtained from this study may be helpful in the development of a probenecid transdermal drug delivery system.in vitro probenecid permeation through dermatomed abdominal pig skin was investigated. The permeability of different probenecid percentages dispersed in vehicles as vaseline, carbopol/ethanol/water and carbopol/propylene glycol was tested. The 1.3% L-menthol addition, as permeation enhancer, over probenecid/vaseline formulations showed the highest values for both, flux and permeation coefficient. Permeation experiments of the probenecid formulations in carbopol/ propylene glycol showed that the carbopol/probenecid concentration relation is the most important issue to be considered. Comparatively to lipophilic vehicle (vaseline), carbopol dispersions seen to be more convenient as vehicle for topical administration of probenecid. The results obtained from this study may be helpful in the development of a probenecid transdermal drug delivery system.